Connect with us

Hi, what are you looking for?

Water for Injection Market Trends and Forecast 2022-2031

Water for Injection Market Outlook 2031
  • The global water for injection market was valued at US$ 21.5 Bn in 2021
  • The global market is projected to advance at a CAGR of 9.5% from 2022 to 2031
  • The global water for injection market is anticipated to reach more than US$ 53.8 Bn by the end of 2031

Water for Injection Market Introduction

Water for injection is an important component in several pharmaceutical and life sciences operations. Sterile water for injection USP is a colorless, odorless liquid that is clear. Controlling bacteriostatic water quality during manufacturing, storage, and distribution processes, including microbiological and chemical quality, is a major concern. Water for injection is sterile, hypotonic, and non-pyrogenic, with no bacteriostatic or antimicrobial agents. It is used as a diluent or solvent suitable for intravascular injection. Water for injection is a form of sterile water used to deliver medications or drugs to patients intravenously. Besides making solutions, it is also used as a cleaning agent.

Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84885

Rise in Demand for Generic Medicines to Drive Global Water for Injection Market

Demand for medicines such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides is rising. The biopharmaceuticals market has witnessed strong growth in the past few years, and the trend is expected to continue during the forecast period. The market is anticipated to grow at a high CAGR, nearly twice as fast as the market for conventional pharmaceuticals, in the near future. The biopharmaceutical industry is driven by significant unmet medical needs in the treatment of chronic illnesses, patent expiration of branded biologic drugs that have opened the door for biosimilars, and the prolific production of clinically effective drugs.

Development and expansion of manufacturing facilities suitable for generic formulations is expected to garner more attention from leading companies during the forecast period. This is likely to result in an increase in production of specialty generic injectable products. Demand for sterile water for injection is anticipated to rise due to the growth of biopharmaceutical and generic injectable industries, as bacteriostatic water for injection is an essential component of these industries.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84885

Increase in Prevalence of Cardiovascular Diseases and Cancer Augmenting Global Market

Majority of medications used to treat diabetes, cardiovascular diseases, and cancer are in the injectable dosage form. New drug formulation, increase in demand for cancer treatment, and rise in access to healthcare facilities in emerging economies are the key factors likely to propel the market during the forecast period. Cardiovascular diseases (CVDs) are disorders of the heart and blood vessels. Changing lifestyles and rapidly rising obesity rates are the major contributors to the increase in the number of people suffering from CVDs. According to the WHO, CVDs are the leading cause of death globally, accounting for an estimated 17.9 million deaths each year. Water for injection market manufacturers are making use of these findings to capitalize on incremental opportunities.

Development of Formulate Parenteral Drugs to Benefit Market Stakeholders

The formulate parenteral drugs segment is projected to dominate the global market, with 60% share by 2031. Development of generic parenteral formulations is a more rapid process compared to branded ones, as these products are exempt from the requirement to conduct clinical trials and toxicity studies. Large numbers of players are entering the global generic injectable market with cost-effective alternatives to branded products. This is leading to the development of parenteral formulations. Need for bacteriostatic water for injection is expected to rise in sync with the growth of biopharmaceutical and generic injectable industries during the forecast period.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=84885

High Demand for Water for Injection in North America

Demand for biopharmaceuticals such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides is increasing for the treatment of chronic diseases such as cancer, neurological diseases, and chronic kidney diseases in North America. Thus, the water for injection market demand is growing in the region due to the rise in development of plasma fractionation and specialty enzymes. Key players are making strategic investments in North America. This is likely to boost the water for injection market size in the region during the forecast period.The water for injection market in North America is also anticipated to be driven by well-established healthcare infrastructure, increase in production of distilled water, and high healthcare spending in the region.

Analysis of Key Players in Global Water for Injection Market

The global water for injection market is fragmented, with the presence of a large number of prominent players. Most of the companies are investing significantly in the expansion of product portfolios and mergers & acquisitions. Merck KGaA, Baxter International, Inc., Johnson & Jonson Services, Inc., Abbott, Thermo Fisher Scientific, Pfizer, Inc., Sun Pharmaceutical Ltd., Serum Institute of India, and Novartis are the prominent players operating in the global water for injection market.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84885

Key Developments in Global Water for Injection Market

  • In July 2021, Nexus Pharmaceuticals introduced potassium chloride in water for injection in single-dose IV bags of 10mEq/100mL, 10mEq/50mL, and 20mEq/50mL. Potassium chloride injection is used to treat potassium deficiency when oral replacement is not possible.
  • In July 2020, Hikma Pharmaceuticals, a multinational pharmaceutical company, launched Dacarbazine for injection with dextrose water solution for the treatment of metastatic malignant melanoma. The reconstituted solution could be further diluted with 5% dextrose water injection or sodium chloride injection and administered as an intravenous infusion.
  • In August 2018, Hikma Pharmaceuticals plc announced the release of Sterile Water for Injection, USP, 10mL. Hikma’s Sterile Water for Injection, USP is only for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection according to the manufacturer’s instructions.
  • In March 2017, Merck launched the Milli-Q IQ 7000 system. The system is seventh-generation Milli-Q water purification innovation. This system is the first to use environment-friendly, mercury-free UV lamps. The system’s ergonomic and small design reduces waste, accelerates research, and increases productivity.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=84885

Each of these players has been profiled in the water for injection market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.

More Trending Reports by Transparency Market Research:

Nanoparticle Contract Manufacturing Market – https://www.transparencymarketresearch.com/nanoparticle-contract-manufacturing-market.html

Nanorobotics in Medicine Market – https://www.transparencymarketresearch.com/nanorobotics-in-medicine-market.html

Anticoagulant Reversal Drugs Market – https://www.transparencymarketresearch.com/anticoagulant-reversal-drugs-market.html

Macular Degeneration Treatment Market – https://www.transparencymarketresearch.com/macular-degeneration-treatment-market.html

PET Radiotracer Market – https://www.transparencymarketresearch.com/pet-radiotracer-market.html

Gemcitabine HCL Market – https://www.transparencymarketresearch.com/gemcitabine-hcl-market.html

Ketoanalogue for Kidney Disease Market – https://www.transparencymarketresearch.com/ketoanalogue-for-kidney-disease-market.html

Gout Therapeutics Market – https://www.transparencymarketresearch.com/gout-therapeutic-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Websitehttps://www.transparencymarketresearch.com
Bloghttps://tmrblog.com
Email: [email protected]

You may also like:

Tech & Science

Oxford Research reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes.

Tech & Science

AI can replace you guys, too. All it needs is a script, you know.

Tech & Science

The CDC revealed Friday it is now tracking a new COVID-19 variant of concern around the U.S. known as XBB.

Tech & Science

Avian flu wiped out 50.54 million birds in the United States this year, making it the country’s deadliest outbreak in history.